# OnCo record wu-yi-long (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/wu-yi-long/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "wu-yi-long" ;
  schema:name "Yi-Long Wu"@en ;
  schema:description "Co-led ADAURA and IPASS, the trials that made EGFR-targeted pills standard before and after surgery."@en ;
  schema:url <https://onco.cc/people/wu-yi-long/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.gdghospital.org.cn>, <https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20YL%5BAuthor%5D%20Guangdong%20Lung%20Cancer%20Institute%20osimertinib> ;
  schema:jobTitle "Professor; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/osimertinib/> ;
  onco:companies <https://onco.cc/companies/ctong/> ;
  onco:institutions <https://onco.cc/institutions/guangdong-provincial-peoples-hospital/> ;
  onco:trials <https://onco.cc/trials/adaura/> ;
  schema:affiliation <https://onco.cc/institutions/guangdong-provincial-peoples-hospital/> .